Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx1a monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx3a monoclonal antibodies to study transcriptional regulation and embryonic development.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx3b monoclonal antibodies to study transcriptional regulation and embryonic development.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pknox monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.
Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for AF5, a proto-oncoprotein associated with pediatric and adult acute leukemia.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Meis monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.